A new latex agglutination test for rubella virus was used to test sera with a hemagglutination inhibition titer of -8 (97 specimens) or >256 (158 specimens). Maximum latex agglutination test sensitivity was achieved when low-titer sera were tested undiluted and high-titer sera were diluted (1:10). A modification of the protocol of the manufacturer resulted in a latex agglutination-hemagglutination inhibition agreement of 96.7%. Table 1 . Of the 76 sera with no detectable antibody (titer, <8), agglutination of latex particles occurred in 5 instances when sera were tested undiluted (1:1) and in 1 instance when sera were tested diluted (1:10). All 21 sera containing low levels of antibody (titer, 8) were positive by the undiluted procedure, although 6 of the 21 diluted sera were negative. LA test results were negative in 6 of the 158 high-titer, undiluted sera (3256), but all 158 specimens were positive when diluted.
The detection of humoral antibodies is the only feasible means available to clinical laboratories for assessing immune status to rubella virus. Radioimmunoassay, enzyme-linked immunosorbent assay, passive hemagglutination, and indirect immunofluorescence are among newer techniques developed for the detection of these antibodies. However, these are relatively complex, time-consuming techniques, and several require special equipment. Reports indicate acceptable agreement of these testing systems with the hemagglutination inhibition (HAI) test (1, 3, 5, 6, 8) Table 1 . Of the 76 sera with no detectable antibody (titer, <8), agglutination of latex particles occurred in 5 instances when sera were tested undiluted (1:1) and in 1 instance when sera were tested diluted (1:10). All 21 sera containing low levels of antibody (titer, 8) were positive by the undiluted procedure, although 6 of the 21 diluted sera were negative. LA test results were negative in 6 of the 158 high-titer, undiluted sera (3256), but all 158 specimens were positive when diluted.
In addition to the six negative results obtained with undiluted sera, seven other sera exhibited weak agglutination (Table 2 ). These weak reactions were observed in LA testing of five sera with a titer of 256, one serum with a titer of 512, and one serum with a titer of 1,024. No reactivity was seen with four sera (titer, 256) or two sera (titer, 512). The manufacturer states that any agglutination constitutes a positive test. However, careful scrutiny was necessary to make an observation of agglutination with the seven high-titer sera. Meegan et al. (4) noted weak agglutination in six instances when hightiter sera were tested undiluted, but upon retesting these samples at a 1:2 dilution, the agglutination pattern was strong. Similar results were observed in our study. All 13 sera, which were nonreactive (6 specimens) or weakly reactive (7 specimens) undiluted, were strongly reactive when diluted (1:10). This indicates that a prozone phenomenon needs to be considered when using the undiluted procedure. Although a direct correlation between this phenomenon and the HAI titer at high levels was not demonstrated J. CLIN. MICROBIOL. The greatest LA reactivity was obtained with the undiluted protocol when sera had a low HAI titer (s8) and with the diluted protocol when sera had a high HAI titer (>256). If LA and HAI tests are considered equally specific, a latex testing protocol which requires that all sera be initially tested undiluted, followed by repeat testing of all nonreactive sera at a 1:10 dilution, would give maximum sensitivity. In our study, this protocol would result in LA-HAI test agreement with 321 of 332 sera (96.7%).
Therefore, we recommend a change in the protocol of the manufacturer for testing undiluted sera. Sera should be initially tested undiluted, and nonreactive sera should be further tested at a 1:10 dilution. Any agglutination in either method should be interpreted as positive. This change will provide maximum sensitivity and eliminate the reporting of false-negative results due to a prozone reaction.
